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Today the management of solid waste and wastewater is a major concern for humanity. In the last decade, 
traces of pharmaceuticals have been reported in the water cycle and have raised concerns among regulators, 
water suppliers and the public regarding the potential risks to human health. This study evaluated solid 
waste management in the state of Minas Gerais and concluded that the main fate of hazardous waste 
has been incineration, while the non-hazardous waste has been recycled or sent to landfills. However, 
complaints to the Environmental Agency - FEAM have indicated that a significant number of companies 
just send their hazardous wastes to landfills or even to garbage dumps, thus highlighting the urgent need 
for adequate waste management in Minas Gerais. Most of the pharmaceutical companies in Minas Gerais 
use conventional wastewater treatment. Mass spectrometry with electrospray ionization (ESI-MS) showed 
that the treatment routes adopted by the two 2 selected pharmaceutical industries were not effective enough 
since residues and degradation products of antibiotics were detected. The physicochemical analysis 
of the effluents showed variability in their characteristics, which may influence their treatability. The 
degradation assay with Fenton’s reagent stood out as a promising route in achieving a higher removal 
capacity compared to the conventional treatment. This study contributes to enhancing our knowledge 
of the management of wastewater as well as of solid waste from the pharmaceutical industry in Minas 
Gerais and points out the need for further research.
Uniterms: Pharmaceutical industry/management of waste. Solid waste/management/pharmaceutical 
industry. Waste water/management/pharmaceutical industry. Brazil/pharmaceutical industry.
Atualmente, a gestão de resíduos sólidos e águas residuais é uma grande preocupação para a humanidade. 
Na ultima década, a detecção de traços de medicamentos no ciclo da água tem sido reportada e tem gerado 
preocupação entre os agentes reguladores, fornecedores de água e público devido os riscos potenciais 
para a saúde humana. As empresas farmacêuticas, em Minas Gerais, aplicam tratamentos convencionais 
para as águas residuais e não há praticamente avaliação sobre a eficiência de remoção de resíduos de 
antibióticos. Este estudo avaliou a gestão de resíduos sólidos e concluiu que o destino principal foi, para 
o caso de resíduos perigosos, a incineração e, para os não perigosos, a reciclagem e o aterro sanitário. 
No entanto, denúncias apresentadas à Agência Ambiental - FEAM indicam que número significativo 
de empresas envia seus resíduos perigosos para aterros sanitários e até mesmo para lixões, ressaltando, 
assim, a necessidade urgente de adequada gestão dos resíduos gerados. A espectrometria de massas 
com ionização electrospray (ESI-MS) mostrou que a rota de tratamento convencional adotada por duas 
empresas do setor selecionadas não foi suficientemente eficaz, uma vez que resíduos e fragmentos de 
antibióticos foram detectados. Os resultados da caracterização físico-química de efluentes evidenciaram 
suas características variáveis, que podem influenciar a sua tratabilidade. O ensaio de degradação com o 
reagente Fenton destaca-se como caminho promissor para alcançar maior remoção. Este estudo contribuiu 
para elevar o nível de conhecimento no gerenciamento de águas residuais e resíduos sólidos da indústria 
farmacêutica no estado de Minas Gerais e evidenciou a necessidade de estudos mais detalhados.
Unitermos: Indústria farmacêutica/gestão de resíduos. Resíduos sólidos/gestão/indústria farmacêutica. 
Águas residuárias/gestão/indústria farmacêutica. Brasil/indústria farmacêutica.
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INTRODUCTION
Although the production of pharmaceuticals in 
massive quantities has been ongoing for many decades 
already, it was only in the past decade that scientific studies 
worldwide have increasingly examined associated effluent 
and waste generation and their respective impact. Many 
surveys and studies have confirmed the presence of phar-
maceuticals in effluents, municipal wastewaters, surface 
waters, groundwater and, to a lesser extent, drinking water. 
The ongoing global process of urbanization and population 
growth has increased the demand for clean water, lead-
ing to an increase in the volume of effluent to be treated 
(Bolong et al., 2009).
There is also a growing demand for new products 
such as antibiotics, which leads to an increase in new 
emerging contaminants released into the environment, 
typically at levels in the nanogram to low microgram 
per liter range, often without any knowledge of potential 
related risks to humans and damage to ecosystems. Anti-
biotics were recently ranked as a major risk group because 
of their high toxicity to algae and bacteria, even at low 
concentrations. These risks include an increase in the oc-
currence of fatal cases of hospital-borne infections with 
such pathogens that develop resistance towards antibiotics 
(Hernando et al., 2006; Watkinson et al., 2009).
A preliminary survey of the databases of the Envi-
ronmental Agency of Minas Gerais state (FEAM) in the 
licensing process of the pharmaceutical industry, showed 
inconsistencies in data on the monitoring of solid waste 
production as well as noncompliance with the require-
ments to meet effluent discharge regulations. Inspections 
in the industries found that waste management is still 
in its infancy and that the large diversity in production 
results in the generation of a highly fluctuating effluent 
composition. This greatly impairs the efficiency of current 
treatment systems.
It is worth mentioning that in Brazil there is no 
legislation that limits the release of so-called emerging 
contaminants. Studies in Minas Gerais on the removal of 
pharmaceutical residues, especially residual antibiotics 
in effluents, are rare. The pharmaceutical companies in 
Minas Gerais use conventional treatment, and there is no 
evaluation of removal efficiency. This scenario explains 
the importance of this work aimed at evaluating solid 
waste management by the pharmaceutical industry as 
well as characterizing the generated effluents, develop-
ing analytical methods for detecting the presence of 
residual antibiotics and degradation products, and test-




The study began with the evaluation of the man-
agement of solid waste generated by the pharmaceutical 
industry in Minas Gerais State based on the data from 
FEAM. This was performed by an extensive data survey, 
tapping various sources, such as i) the outstanding data-
base of FEAM, more specifically the production processes 
of the companies, ii) the effluent and solid waste monitor-
ing reports of environmental licenses, iii) the records of 
monitoring and inspections of businesses, and iv) reports 
of industrial inventories of solid waste for the years 2003, 
2007, 2008, 2009 and 2010.
Pharmaceutical companies
Two Minas Gerais-based pharmaceutical compa-
nies, company 1 and company 2, holding environmental 
certifications, were selected to be partners in this work. 
Based on their environmental commitment, the compa-
nies were visited to study the production process and the 
generation of waste and effluents, as well as the respec-
tive wastewater treatment plants. Effluents, generated in 
the production lines of antibiotics, were collected at three 
different times of the year and also before and after the 
treatment plant effluent. Both produce a wide variety of 
drugs, among them antimicrobial drugs (antibiotics) and 
both have an Effluent Treatment Plant (ETP) prior to dis-
charge in the environment. While company 1 segregates 
the effluent generated at the line of antibiotics from the 
others and treats it in batches, company 2 produces three 
different antibiotics, does not segregate the antibiotic ef-
fluent from the others, and treats effluents continuously. At 
the time of the study, no one had a performance evaluation 
of their respective ETPs.
Company 1 produces the antibiotic amoxicillin 
(AMO), which belongs to the beta-lactam class. Company 
2 produces the antibiotics norfloxacin (NOR), sulfagua-
nidine (SG) and sulfadiazine (SD). Company 1 treats the 
effluent through the hydrolysis of the beta-lactam ring, 
abruptly changing its pH. The effluent pH in the ETP rises 
from 3.5 to values between 9 and 12. After this treatment, 
the pH is adjusted to pH 7.0 to 8.5, at which the effluent is 
then suitable for directly discharged into the river.
ESI-MS and GC experiments
Chemical analyses were performed using a Finni-
gan Surveyor Plus Auto Sample gas chromatograph (GC) 
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(ThermoScientific, San Jose, CA, USA) and Supelco C18 
column (Sigma Aldrich, Bellefonte, PA, USA) with 3-μm 
particle size and L x I.D. of 15 cm, 2.1 mm. HPLC-grade 
acetonitrile and methanol (Vetec, Sao Paulo, Brazil) along 
with Milli-Q water (Millipore, Milford, MA, USA) were 
used to prepare the solutions. The analytical conditions 
were isocratic elution with methanol/Milli-Q water (8:2 
v/v). The identification of the eluted compounds was per-
formed by mass spectrometry with electrospray ionization 
(ESI-MS) (ThermoScientific, San Jose, CA, USA). Mass 
spectra were obtained from an average of 50 scans, each 
one requiring 0.02 s, operating in the positive ion mode. 
The analysis conditions were: spray voltage of 5 kV, sheath 
gas (N2) flow rate of 20 units, auxiliary gas flow rate of 
15 (arbitrary units), capillary voltage of 44 V, and heat 
capillary temperature of 280°C, and tube lens voltage of 
119 V (Oliveira et al., 2012). The solutions were directly 
injected into the ESI source at a flow rate of 20 µL/min 
using a 500 µL microsyringe (Hamilton, Reno, NV, USA).
Table I shows the analysis conditions for the mass 
spectrometer (MS-ESI).
Stock standard solutions of the analytes AMO, SG, 
SD and NOR were prepared with concentration in the range 
50 to 100 mg/L. The standards were diluted in Milli-Q water 
to obtain concentrations below 1.0 mg/L for analysis by 
ESI-MS. The stock solutions and diluted standards were 
stored in amber vials in a refrigerator for later use.
For the effluents of companies 1 and 2, standard 
solutions of each antibiotic were prepared individually at 
a concentration of 500 µg/L and a standard solution con-
taining the four analytes (AMO, NOR, SD and SG) at a 
concentration of 500 µg/L for calibration of the operating 
conditions of mass spectrometry of the samples (Oliveira 
et al., 2012). The standard solutions were prepared using 
samples of antibiotics that were kindly provided by the 
companies.
Characterization of industrial wastewater
The extraction of the effluent samples was performed 
using the method described by Goulart (2004), making use 
of low-temperature extraction. Before being submitted to 
the extraction process, samples were filtered using a simple 
filtration system. Accordingly, 10 mL of the filtrate were 
added to a test tube with 20 mL of HPLC-grade acetonitrile. 
The test tubes were placed in a freezer for 24 h. Afterwards, 
the liquid part obtained (solute concentrated in acetonitrile) 
was filtered using a 0.45-mm Millipore filter. The filtrate 
was transferred to amber vials and stored in the refrigerator.
Parameters to characterize the effluents were pH, re-
dox potential, conductivity, alkalinity, total organic carbon 
(TOC), total carbon (TC), total nitrogen (TN), ammonia 
nitrogen, nitrate, nitrite, and sulfate; all were determined 
by conventional methods, established by the Standard 
Methods for the Examination of Water and Wastewater 
(APHA, 2005).
The determination of dissolved organic carbon and 
total nitrogen were performed on a VCSH Shimadzu TOC 
instrument (Shimadzu Scientific Instruments, Kyoto, 
Japan) with the measurement unit for total nitrogen and 
TNM-1 autosampler ASI-V. The samples were previously 
filtered through 45-mm membranes. Nitrate and nitrite 
were determined by ion chromatography (ThermoSci-
entific, San Jose, CA, USA) on a Dionex ICS1000 chro-
matograph, IonPac AS 22 column, 2 mm x 250 mm, with 
separation via ion exchange using isocratic elution and 
conductivity detection with ion suppression,. The opera-
tion conditions were typically as follows: flow rate = 0.25 
mL/min.L, 0.8 mmol/L NaHCO3 and 4.5 mmol/L Na2CO3.
Degradation tests with Fenton’s reagent
To investigate the effluents generated at different 
treatment stages in the production plant of amoxicillin, 
degradation tests were performed by advanced oxidation 
with Fenton’s reagent. The tests were conducted at room 
temperature, at pH 3.5, and the ratio of H2O2:C was set at 
7:1, this value being close to stoichiometric, and H2O2:C 
was 10:1 to work with 40% excess peroxide. The miner-
alization of AMO during the experiments was evaluated 
by measuring the decay of total organic carbon.
RESULTS AND DISCUSSIONS
Management of solid waste by the 
pharmaceutical industries in Minas Gerais State
The pharmaceutical industry in Minas Gerais consists 








Voltage (kV) 5.0 5.0 5.0 5.5
Carrier gas (mL/ min) 25 15 20 5
Auxiliary gas (mL/min) 0 0 10 0
Lenses 69.8 -125.3 74.7 94.7
Note: Capillary temperature = 285 oC
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of 114 companies and employs approximately 10,800 peo-
ple. It focuses almost exclusively on the domestic market 
and its main products are generic drugs and herbal medi-
cines. Most companies are concentrated in the Metropolitan 
Region of Belo Horizonte (50%), about 20% are located in 
southern Minas Gerais, and the rest are distributed in the rest 
of the state (Silva, 2011, personal communication). There 
are, however, many more products that all contribute to the 
wide variety of inputs and raw materials and particularly to 
the generation of solid wastes and industrial effluents, thus 
directly influencing their management.
The ten most-frequently generated waste types 
represent almost the entire quantity of waste generated. 
Among those ten are three waste types, classified accord-
ing to ABNT 10.004/2004 as hazardous, which correspond 
to 73.6% of the total of waste generated (FEAM, 2010). 
In total, we observed the generation of about 100 different 
types of solid waste. Annually, the companies are required 
to send to FEAM an inventory of industrial solid wastes. 
This inventory discerns between those solid wastes that re-
main in-house and those with an external destination. The 
main form of waste disposal has been the incineration of 
hazardous waste (Class I). Non-hazardous waste (Class II) 
is sent to both recycling and landfills. However, complaints 
to the environmental agency FEAM have indicated that a 
significant number of companies do not properly manage 
their wastes, where the disposal of hazardous waste is 
usually in landfills and even garbage dumps.
Identification of amoxicillin metabolites
Amoxicillin (AMO) has a structure with three chiral 
centers, which accounts for the existence of eight optically 
active isomers. However, only AMO has antibacterial activ-
ity. Additionally, the presence of a beta-lactam ring makes 
this molecule readily cleavable. Two major metabolites of 
AMO are amoxicilloic acid (AMA) and amoxicillin diketo-
piperazine-2,5-dione (DIKETO). It is known, however, that 
AMA has a high allergenic potential (Reyns et al., 2008).
Figure 1 shows the main products obtained from the 
acidic or basic hydrolysis of AMO. In the acidic medium, 
AMO hydrolysis may lead to the formation of DIKETO. 
The existence of this isomer in ETPs can complicate the 
analysis of AMO by conventional analytical techniques, 
both for ultraviolet (UV) detection and mass spectrometry 
(MS). However, the presence of the fragment due to a mass/
charge (m/z) of 149 is characteristic of AMO, which is iden-
tified whether or not amoxicillin is present in the medium.
It is known that the identification of beta-lactam 
(BL)-type antibiotics may be impaired due to the deg-
radation of these compounds. BL rings are susceptible 
to hydrolysis due to their tendency to destabilize and 
also due to the electrophilicity of the carbonyl carbon, 
which can undergo nucleophilic attack. In some methods 
reported in the literature, many of these antibiotics show 
a low recovery rate (<30%) and the inability to detect the 
analytes is mostly explained by the low rates of recovery in 
the extraction procedure (Watkinson et al., 2007). Despite 
the reported problems in detecting BL antibiotics, there are 
reports on the presence of amoxicillin in municipal sewage 
(Boxall et al., 2003; Watkinson et al., 2009; CALAMARI 
et al., 2003), of ampicillin (AMP), mezlocillin (MZC), 
flucloxacillin (FXC) and piperacillin (PPC) in surface 
waters on the order of 48 ng/L and AMO in river water at 
concentrations less than 10 ng/L (Christian et al., 2003).
Several analytical methods to determine beta-lactam 
antibiotics in the environment in different matrices (in 
its natural form, soil and waste water) are reported in the 
literature. Most methods employ liquid chromatography 
coupled with a mass spectrometer (LC-MS) or LC-MS-
MS, due to its high sensitivity and ability to provide 
confirmation of the compounds being detected. The mass 
spectrometers used are for the most part single or triple 
quadrupole. In the present work, electrospray ionization 
mass spectrometry (ESI-MS) (Oliveira et al., 2012) was 
employed along with the extraction method described by 
Goulart (2004).
Effluent analyses from company 1 by ESI-MS
The analysis of the pattern of amoxicillin operating 
in the positive ion mode ESI (+) showed the two peaks 
FIGURE 1 - Chemical structure of amoxicillin (AMO) and its metabolites, amoxicilloic acid (AMA) and amoxicillin 
diketopiperazine-2,5-dione (DIKETO).
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characteristic of this substance: m/z 366, together with 
the AMO of the protonated molecular ion [M + H]+ and 
the peak with m/z 349, associated with the fragment ion 
[M + H]+ losing a molecule of NH3 (Figure 2). Effluent 
samples were collected before and after treatment. The 
preliminary results indicate the persistence of the drug. 
This prompted suggested adjustments in the ETE to 
improve the treatment efficiency. The company readily 
accepted the suggestions and increased the concentra-
tion of sodium hydroxide (NaOH) from 40 g/L to 80 
g/L, which resulted in a pH increase from 12 to 13. The 
company also increased the residence time from 20 to 
40 minutes without change in the agitation form in the 
treatment reactor tank.
The molecular ion with m/z 366 corresponding to the 
starting material AMO (or in the rearranged forms AMO-
R1/R2) was found in all samples analyzed. However, 
other fragments were detected, such as that with m/z 349 
(AMO-F1: loss of NH3, 17 g/mol and one corresponding 
to the final product, with m/z 149 (AMO-F2), and this 
product was obtained from the cleavage of the rearranged 
intermediate (AMO-R1). These data show that AMO was 
not totally degraded in more hydrophilic compounds, but 
with no cleavage or oxidation of the aromatic moiety. Be-
sides, it is noteworthy that amoxicilloic acid (AMA) (m/z 
384, M-H+), a powerful allergenic agent, was detected. 
In fact, AMA is one of the most common metabolites 
of alkaline hydrolysis of AMO, and there is no official 
information about the allowable limits of this compound 
in the environment.
Figure 3 displays representative ESI mass spectra in 
the positive ion mode, ESI(+)-MS, of an acetonitrile solu-
tion of effluent of company 1. As a common feature, the 
spectra of the effluents exhibit abundant ions of m/z 385, 
349, 343 which characterized AMO and other fragments 
of AMO (Nägele, Moritz, 2005). These results showed 
that the alkaline hydrolysis treatment had not been effec-
tive since AMO residues and fragments characteristic of 
the antibiotic were also detected in the samples after the 
treatment.
Effluent analyses from company 2 by ESI-MS
Company 2 did not segregate the antibiotic effluent 
from the other effluents generated from the entire produc-
tion of drugs, and treated continuously according to the 
conventional physicochemical treatment. The effluent is 
therefore a complex mixture containing several active 
ingredients from the entire production, which includes the 
effluents coming from the production lines of antibiotics 
and hormones. Figure 4 shows the mass spectrum by ESI 
(+) of a standard mixture of NOR, SD and SG (Figure 4).
FIGURE 2 - Proposed degradation of AMO in effluents after alkaline hydrolysis.
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FIGURE 4 - Mass spectrum (ESI+) of a mixture of NOR, SD and SG reference materials at 500 mg/L.
FIGURE 3 - Mass spectrum (ESI+) for company 1 effluents after alkaline hydrolysis.
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The detection and identification of NOR, SD and SG 
in the effluents showed that they were not totally degraded 
to more hydrophilic compounds. The molecular ion with 
m/z 215 corresponded to the starting material SG (or in the 
rearranged forms SG), m/z 320 corresponded to NO (or in 
the rearranged forms NO), and m/z 273 was SD (Figure 5).
FIGURE 5 - Mass spectrum (ESI+) for effluents of company 2 after alkaline hydrolysis.
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Characterization of industrial wastewater
According to the effluent and solid waste monitoring 
reports of the environmental licenses in the database of 
FEAM, most of the pharmaceutical companies in Minas 
Gerais State do not characterize their generated waste and 
use conventional treatment methods. They do not develop 
efficient methods to indicate the presence of toxins before 
and after the release of effluents. The characterization 
of the effluent was performed with the effluent from the 
company 1 due to the fact that this company segregates 
the effluent generated in the production line of antibiotics, 
and therefore, it was less complex.
The industrial effluents were collected in July 2010 
(E1), September 2010 (E2), and October 2010 (E3) and 
showed distinct characteristics, confirming seasonality in 
production stages. The level of DOC (dissolved organic 
carbon) of effluents E1, E2 and E3 in different stages of 
treatment was highly variable, with removal rates ranging 
from 6 to 97% DOC.
The removal of nitrogen in the three effluents studied 
was very low, which may indicate the presence of frag-
ments of the molecule AMO in the effluent. Nitrogen in 
the molecule is linked to the AMO b-lactam ring and the 
thiazolidine ring, as well as amino groups. This may indi-
cate that the treatment can break the b-lactam ring, but the 
degradation products of AMO remain in the effluent. NO2 
was below the detection limit, supported by the value of 
the redox potential of the samples. The samples showed 
low conductivity values due to low ion concentrations in 
solution. The Cl- content was low, which minimizes its 
possible interference as a contender for the • OH radical 
treatment with Fenton’s reagent.
The results of the physicochemical characterization 
of the effluent showed variability in their characteristics, 
indicating that the batch formulation process showed 
significant differences, which may influence effluent treat-
ability, corroborating the study of Mascolo et al. (2010).
Degradation of the effluent (E1) by advanced 
oxidation process (AOP) with Fenton’s reagent
The effluents generated in different treatment stages 
in the amoxicillin production plant were submitted to deg-
radation tests by advanced oxidation with Fenton’s reagent 
with the effluent E3 for the points P1 (raw effluent) and 
P3 (effluent after acidification). The organic load found 
for E1 as DOC was 1484 mg/L, and at E3 DOC was 770 
mg/L. We evaluated their degradation via the photo-Fenton 
process and investigated the optimum conditions (Trovó 
et al., 2008; Ay, Kargi, 2010).
The effluents studied in this research showed dis-
crepant results, both in the degradation assay with Fen-
ton’s reagent and the determinations of DOC. There were 
no differences in physicochemical characteristics and 
DOC content for the three effluents studied, as shown by 
Mascolo et al. (2010). In advanced oxidation tests with 
Fenton’s reagent the E1 effluent, collected at point P1, 
showed a DOC removal rate of 36%, possibly indicating 
the presence of refractory fractions. For E3, collected 
at point P1, the removal rate was 74% DOC (Figure 6). 
Since the treatment process was carried out in batches, 
this type of effluent showed quite different physical and 
chemical characteristics. Melero et al. (2009) obtained a 
59% reduction in TOC for a real wastewater with differ-
ent active ingredients, which is treated by heterogeneous 
catalytic oxidation with H2O2 and iron oxide mesostructure 
materials.
For E3 (collected at the ETP outlet), the results indi-
cated 85% removal of DOC, higher than the values found 
for E3 (collected at the ETP inlet), which showed a DOC 
removal rate of 70% (Figure 7). The tests were conducted 
at room temperature, at pH 3.5, and the ratio H2O2:C was 
set at 7:1, close to the stoichiometric value, and 10:1 to 
work with 40% excess peroxide.
CONCLUSIONS
Advances in analytical technology have been a key 
factor driving enhanced detection of contaminants as well 
as improvements in the wastewater treatment process.
These results showed that the alkaline hydrolysis 
treatment was not effective since AMO residues and frag-
ments characteristic of the antibiotic were also detected in 
the samples after treatment. The presence of ion m/z 149 
can lead to two conclusions: i) AMO was present in the 
effluent (because degradation product 366 could be the 
TABLE II - Characterization of the effluents E1, E2, E3, before 
hydrolysis
Parameter E1 E2 E3
TOC (mg/L) 1484 486 770
N total (mg/L) 15.1 24.5 26.3
Condutivity (µS) 15.1 24.6 26.3
Redox potential (mV) 770 521 510
Chlorides Cl- (mg/L) 15.6 23.9 1.10
Sulfates SO42- (mg/L) 6.98 1.81 0.94
Nitrate NO3- (mg/L) 1.19 1.67 1.23
Nitrite NO2- (mg/L) < 0.05 < 0.05 < 0.05
Note: NO2- <0.05 mg/L: Limit of detection
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FIGURE 6 - DOC removal efficiencies in Fenton reactions in pharmaceutical wastewater E1 and E3, molar [H2O2]/[DOC] ratio = 
10:1, [H2O2]/[Fe2+] ratio = 10:1 and pH = 3.3.
FIGURE 7 - Degradation of pharmaceutical wastewater E3 in Fenton reactions before and after alkaline hydrolysis treatment, molar 
[H2O2]/[DOC] ratio = 7:1, [H2O2]/[Fe2+] ratio = 10:1, and pH = 3.3.
result of an isomer of AMO) and ii) the AMO molecule 
was broken down.
It is important to highlight the identification of the 
presence of the characteristic degradation product amoxi-
cilloic acid (AMA), which has a high allergenic potential. 
The results indicated that the treatment in both companies 
is still not effective and needs adjustments. The advanced 
oxidation processes associated with segregation stands out 
as a promising route.
As for solid waste disposal and main destination, the 
survey of the databases of FEAM indicated that a signifi-
cant number of the companies send their hazardous waste 
to landfills and even to garbage dumps, thus highlighting 
the urgent need for an adequate waste management.
This study contributes to enhancing our knowledge 
of wastewater management issues and about solid waste 
from the pharmaceutical industry in Minas Gerais. There 
are undoubtedly many developments to come in the short-, 
medium- and even long-term so that Brazil can achieve a 
higher level of sustainability.
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